Enhancing Sales And Marketing Performance For Oncology Therapeutics Conference, March 2010

Main Category: Conferences
Also Included In: Cancer / Oncology;  Pharma Industry / Biotech Industry
Article Date: 01 Feb 2010 - 6:00 PDT

email to a friend   printer friendly   opinions  

Understanding & implementing best practice approaches to value-based sales in the competitive cancer marketplace

Conference dates: 15th-16th March, 2010
Venue: Brussels, Belgium

This will be the only event looking at "best practice" approaches to selling and marketing high-value cancer drugs, and working in partnership with generalists and specialists such as oncologists, haematologists radiologists and cancer hospitals to provide real value and to improve patient access.

One of the goals, will be to improve seamless coordination between all internal stakeholders in strategic, operational and tactical roles at the global, regional and local level. Such roles would typically include marketing, commercial operations, sales, sales force effectiveness, talent development, training, market access, pricing and reimbursement, product and brand management, as well as oncology medical affairs. As the oncology marketplace is growing rapidly, with a lot of new oncology therapies entering a saturated market, where payers are more risk averse and budget-conscious, many would agree this topic deserves specific and detailed attention and discussion.

Why Attend?

• Understand the complex oncology marketplace, the main commercial drivers and challenges and what is the future outlook.
  
  
• Discover what are the most effective strategic and operational marketing, branding and product management strategies, models and techniques specific for this unique therapeutic area.
  
  
• Develop a better understanding of best practices in sales force effectiveness, account management and opinion leader mapping, specific to cancer.
  
  
• Find out how sales and communications methods are being implemented in the „front-line" of sales, what works and what no longer does.
  
  
• Appreciate how to communicate and provide „real value" to all customers and stakeholders, from HTA and payers, to specialist prescribers, influencers, as well as the cancer patient themselves.

Who will benefit?

Oncology sales, sales force effectiveness, account management, strategic and operational marketing, brand & product management, oncology business unit heads, commercial operations, business intelligence, CRM from pharma and biotech companies who have products on the market (or near to launch). Global/regional and local level.

Agenda request

To request the full agenda please follow this link.

For Booking Information contact:
Erika Vavrovicova
Tel: +421 232 660 382
Fax: +421 232 660 397
erika@nextlevelpharma.com
http://www.nextlevelpharma.com

Source:
Erika Vavrovicova
NextLevel pharma

• Additional
• References
• Citations